<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04633291</url>
  </required_header>
  <id_info>
    <org_study_id>CP279</org_study_id>
    <nct_id>NCT04633291</nct_id>
  </id_info>
  <brief_title>Clinical Study in Healthy Volunteers Evaluating the Performance and Handling of a Urinary Intermittent Catheter With a Newly Developed Swelling Media.</brief_title>
  <official_title>Clinical Study in Healthy Volunteers Evaluating the Performance and Handling of a Urinary Intermittent Catheter With a Newly Developed Swelling Media.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigation is conducted at one site. The study is a single blinded, randomised,&#xD;
      crossover study including 22 healthy men, each catheterised two times with 4-15 days between&#xD;
      the catheterisations. Nurses will perform the catheterisation. As there is a visual&#xD;
      difference in the products, it is only possible to blind the subjects&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 5, 2019</start_date>
  <completion_date type="Actual">November 28, 2019</completion_date>
  <primary_completion_date type="Actual">November 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary endpoint is evaluation of overall discomfort during catheterisation measured by the Visual Analogue Scale (VAS).</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <enrollment type="Actual">22</enrollment>
  <condition>Catheter Site Discomfort</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CP279</intervention_name>
    <description>catheterisations.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Have given written informed consent&#xD;
&#xD;
          2. Be at least 18 years of age and have full legal capacity&#xD;
&#xD;
          3. Be a male&#xD;
&#xD;
          4. Willing to refrain from using analgesics up to 24 hours prior to catheterisation&#xD;
             visits&#xD;
&#xD;
          5. Have a negative urine multistix - erythrocytes (Microscopic haematuria)&#xD;
&#xD;
          6. Have a negative urine multistix:&#xD;
&#xD;
               -  Leukocytes&#xD;
&#xD;
               -  Nitrite Or if positive, subsequent negative for bacterial growth in urine culture&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Abnormalities, diseases or surgical procedures performed in the lower urinary tract&#xD;
&#xD;
          2. Symptoms of urinary tract infections (at least one of the following: frequent&#xD;
             urination, stinging or pain at urination)&#xD;
&#xD;
          3. Participating in other clinical investigations related to urinary tracts system during&#xD;
             this investigation (inclusion to termination) or have previously participated in this&#xD;
             investigation&#xD;
&#xD;
          4. Known hypersensitivity toward any of the investigational device&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rigshopsitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>København Ø</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 5, 2020</study_first_submitted>
  <study_first_submitted_qc>November 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>November 11, 2020</last_update_submitted>
  <last_update_submitted_qc>November 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

